Home/Shionogi/Masahiro Fujita
MF

Masahiro Fujita

Senior Vice President and Chief Financial Officer

Shionogi

Shionogi Pipeline

DrugIndicationPhase
Investigational Oral COVID-19 AntiviralCOVID-19Clinical
Fragile X ProgramFragile X SyndromeClinical
Acute Stroke ProgramAcute Ischemic StrokeClinical
Metabolic Disorders ProgramMetabolic ConditionsClinical
Oncology ProgramCancerClinical
Novel AntibioticsBacterial InfectionsVarious
HIV TherapeuticsHIV/AIDSApproved
Influenza TreatmentsInfluenzaApproved